BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	187,832.08 767.51M	0.50% 931.34
ALLSHR	112,851.69 1,193.66M	0.62% 697.08
KSE30	57,539.97 102.71M	0.43% 247.84
KMI30	265,288.04 70.28M	0.22% 591.63
KMIALLSHR	72,445.67 875.56M	0.46% 332.73
BKTi	55,119.30 60.64M	1.38% 752.01
OGTi	38,641.51 5.08M	-0.37% -142.27

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	66,945.00	70,985.00 66,435.00	-6625.00 -9.01%
BRENT CRUDE	67.71	68.95 66.89	-1.75 -2.52%
RICHARDS BAY COAL MONTHLY	90.00	0.00 0.00	-3.60 -3.85%
ROTTERDAM COAL MONTHLY	100.75	100.75 100.20	1.45 1.46%
USD RBD PALM OLEIN	1,071.50	1,071.50 1,071.50	0.00 0.00%
CRUDE OIL - WTI	63.52	64.67 62.65	-1.62 -2.49%
SUGAR #11 WORLD	14.26	14.44 14.20	-0.18 -1.25%